EcoDrugPlus

Ensembl ID : ENSBGRG00000003338
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSBGRG00000004284
Gene Symbol: -
Cross references: -
126 Possible Orthologues:

Ensembl ID : ENSBGRG00000013699
Gene Symbol: -
Cross references: -
137 Possible Orthologues:

Ensembl ID : ENSBGRG00000013780
Gene Symbol: -
Cross references: -
138 Possible Orthologues:

Ensembl ID : ENSBGRG00000019086
Gene Symbol: -
Cross references: -
90 Possible Orthologues:

Ensembl ID : ENSBGRG00000011063
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSBGRG00000023380
Gene Symbol: -
Cross references: -
74 Possible Orthologues:

Ensembl ID : ENSBGRG00000023421
Gene Symbol: -
Cross references: -
107 Possible Orthologues:

Ensembl ID : ENSBGRG00000024882
Gene Symbol: -
Cross references: -
92 Possible Orthologues:

Ensembl ID : ENSBGRG00000026650
Gene Symbol: -
Cross references: -
297 Possible Orthologues:

Ensembl ID : ENSBGRG00000010935
Gene Symbol: -
Cross references: -
300 Possible Orthologues:

Ensembl ID : ENSBGRG00000010836
Gene Symbol: -
Cross references: -
268 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).